• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: placebo

  • Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
    • in General Medicine
    • — 4 Jan, 2008

    Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

    Peter Tyrer
    Peter Tyrer

    REFERENCE: Lancet 371:57 January 5, 2008
    PETER TYRER, Imperial College, W6 8RP London
    A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
    …
    Read more
    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    • in General Medicine
    • — 9 Dec, 2007

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer
    Terry Gernsheimer

    TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
    An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
    …
    Read more
  • Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety
    • in Public Health
    • — 13 Mar, 2007

    Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety

    Howard Mayer

    Mark Wainberg

    HOWARD MAYER, Pfizer Global Research, New London CT
    MARK WAINBERG, McGill University, Montreal

    Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
    In a population of treatment-experienced HIV-infected subjects, maraviroc plus optimised background
    …
    Read more
    Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
    • in Public Health
    • — 6 Mar, 2007

    Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone

    Roy Steigbigel

    John Mellors

    ROY STEIGBIGEL, State University of New York at Stony Brook
    JOHN W. MELLORS, University of Pittsburgh

    REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
    Raltegravir doubled the antiviral response rate and the
    …
    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: placebo

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.